Zomedica Corp. Quarterly Depreciation in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Zomedica Corp. quarterly/annual Depreciation history and growth rate from Q1 2017 to Q3 2024.
  • Zomedica Corp. Depreciation for the quarter ending September 30, 2024 was $417K, a 111% increase year-over-year.
  • Zomedica Corp. Depreciation for the twelve months ending September 30, 2024 was $1.39M, a 128% increase year-over-year.
  • Zomedica Corp. annual Depreciation for 2023 was $830K, a 94.8% increase from 2022.
  • Zomedica Corp. annual Depreciation for 2022 was $426K, a 60.8% increase from 2021.
  • Zomedica Corp. annual Depreciation for 2021 was $265K, a 13.4% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.39M $417K +$219K +111% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.18M $351K +$175K +99.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1M $334K +$170K +104% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $830K $292K +$218K +295% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $612K $198K +$89K +81.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $523K $176K +$15K +9.32% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $508K $164K +$82K +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $426K $74K -$17K -18.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $443K $109K +$49K +81.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $394K $161K +$106K +193% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $288K $82K +$23K +39% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $265K $91K +$17.6K +23.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $247K $60K -$18.2K -23.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $266K $55K -$22.9K -29.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $288K $59K -$17.4K -22.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $306K $73.4K -$2.64K -3.47% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $309K $78.2K +$8.1K +11.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $300K $77.9K +$8.93K +13% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $292K $76.4K +$14.4K +23.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $277K $76.1K +$22.7K +42.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $254K $70.1K -$16.1K -18.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $271K $68.9K +$41.5K +151% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $229K $62.1K +$25.4K +69.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $204K $53.4K +$29.7K +126% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 $174K $86.2K +$63.3K +276% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $111K $27.5K +$4.68K +20.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $106K $36.7K +$16.4K +80.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $89.6K $23.6K Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-14
Q3 2017 $22.9K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $22.8K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $20.3K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.